Canopy Growth (CGC) Current Leases (2020 - 2026)
Canopy Growth (CGC) reported Current Leases of $10.4 million for Q1 2026, down 9.38% on a YoY basis from $11.5 million in Q1 2025, and up 13.28% sequentially from $9.2 million in Q4 2025.
Canopy Growth (CGC) Current Leases (2020 - 2026) Analysis & Trends
Canopy Growth (CGC) has 7 years of Current Leases data on file, last reported at $10.4 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 9.38% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (down 9.38% YoY), and the FY2026 full-year result was $10.4 million, down 9.38% from the prior year.
- Current Leases grew to $10.4 million in Q1 2026, from $9.2 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $31.6 million in Q2 2024 to a low of $9.1 million in Q2 2025.
- A 5-year average of $17.8 million and a median of $11.5 million in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases surged 196.89% in 2024 and slumped 71.14% in 2025, its largest moves.
- Tracing CGC's Current Leases over 5 years: stood at $26.2 million in 2022, then sank by 60.66% to $10.3 million in 2023, then gained by 29.15% to $13.3 million in 2024, then slumped by 30.66% to $9.2 million in 2025, then gained by 13.28% to $10.4 million in 2026.
- Business Quant data shows CGC's Current Leases at $10.4 million in Q1 2026, $9.2 million in Q4 2025, and $9.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 10.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.45 Mn |
| Dec 31, 2025 | 9.22 Mn |
| Sep 30, 2025 | 9.16 Mn |
| Jun 30, 2025 | 9.11 Mn |
| Mar 31, 2025 | 11.53 Mn |
| Dec 31, 2024 | 13.30 Mn |
| Sep 30, 2024 | 30.87 Mn |
| Jun 30, 2024 | 31.56 Mn |
| Mar 31, 2024 | 11.26 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Sep 30, 2023 | 10.40 Mn |
| Jun 30, 2023 | 10.80 Mn |
| Mar 31, 2023 | 21.02 Mn |
| Dec 31, 2022 | 26.18 Mn |
| Sep 30, 2022 | 28.46 Mn |
| Jun 30, 2022 | 29.72 Mn |
| Mar 31, 2022 | 30.03 Mn |
| Dec 31, 2021 | 30.69 Mn |
| Sep 30, 2021 | 29.32 Mn |
| Jun 30, 2021 | 29.99 Mn |